What's Going On With Tonix Pharmaceuticals Stock Today?
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 ...
Monthly Prescribing Reference19h
FDA to Review Sublingual Cyclobenzaprine for Fibromyalgia Management
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.
Stockhouse9d
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
Tonix expects to hear a decision on NDA acceptance by the FDA in mid-December. If the NDA is accepted, Tonix said the FDA could commit to a decision on approval in 2025, which means TNX-102 SL ...
Nasdaq1mon
Tonix Pharmaceuticals reports Q3 EPS (23c), consensus ($2.93)
Reports Q3 revenue $2.822M, consensus $3.08M. “With our recent NDA submission to the U.S. Food and Drug Administration (FDA), Tonix is excited about the potential of TNX-102 SL to become the ...
Tonix Pharmaceuticals appoints Raudabaugh, Gould as VPs
Holding announced the expansion of its leadership team to support the launch of TNX-102 SL for the management of ...
TipRanks on MSN2mon
Tonix Pharmaceuticals (TNXP) Has a Promising Pipeline but Faces Financial Challenges
The recent outbreak of the mpox virus has thrown companies like Tonix Pharmaceuticals (TNXP) into the limelight as it ...